Loading…
www.usmedschoice.com was found to be unlawfully selling unapproved and misbranded drugs over the internet, including opioids, benzodiazepines, and Schedule II stimulants, in violation of sections 301(a), 301(d), 301(k), 503(b), and 505(a) of the Federal Food, Drug, and Cosmetic Act. The FDA cited particular concern regarding the public health risks posed by the online availability of these high-risk drug products, given the ongoing opioid epidemic, the abuse potential of benzodiazepines (especially when co-used with other substances), and the diversion risk of Schedule II stimulants. The company failed to obtain FDA approval for these new drugs and failed to properly label them as required by law before introducing them into interstate commerce.